Grant Mitchell — The Potential of AI Drug Rep...

In this episode of Infinite Loops, Jim O'Shaughnessy sits down with Angus Fletcher, Professor of Story Science at Ohio State University's Project Narrative and author of multiple books at the intersection of narrative theory, psychology, and brain science. Angus' research challen ...  Show more

In this episode of Infinite Loops, we sit down with author Jonathan Tepper to discuss his extraordinary childhood. In 1985, when Jonathan was seven, his missionary parents moved the family to San Blas — then the heroin capital of Europe — to start a drug rehabilitation center. Jo ...  Show more

When Ziad Obermeyer was a resident in an emergency medicine program, he found himself lying awake at night worrying about the complex elements of patient diagnoses that physicians could miss. He subsequently found his way to data science and research and has since coauthored nume ...  Show more

Vaccine-maker Moderna is also a data company, and that’s enabling it to use AI to drastically reduce drug-development times, Chief Information Officer Brad Miller tells Bloomberg Intelligence’s Sam Fazeli and Mandeep Singh. This episode of the Tech Disruptors podcast looks at a w ...  Show more

In this fascinating episode of Brainfluence, pioneering neuromarketer Dr. Carl Marci discusses how modern technology is impacting our brains. He shares insights from his new book Rewired, explaining how excessive smartphone use and constant multitasking are reducing productivi ...

It may seem intuitive that AI and deep learning can speed up workflows — including novel drug discovery, a typically years-long and several-billion-dollar endeavor. But professors Artem Cherkasov and Olexandr Isayev were surprised to find that no recent academic papers provided a ...  Show more